SiPhox Health key facts
as of Oct 2026- Operator of a biosensing platform intended to provide a handheld device that accepts disposable cartridges.
- SiPhox Health is valued at approximately $185.0M as of Oct 2026, set at its later-stage round, Jan 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $67.2M across 2 recorded rounds; the latest was Early Stage VC (Series A) ($17.0M) in Jul 2023.
- Notable investors include Y Combinator, Alumni Ventures, Khosla Ventures, Metaplanet Holdings, Balaji Srinivasan — 27 tracked in total.
- Status: Privately Held (backing).
Valued at $185.0M at its later-stage round, Jan 2026. Nothing has traded since.
- ·The complete investor list: 27 names
- ·Watch SiPhox Health: the Monday email on marks, rounds and moves
SiPhox Health funding rounds
2 roundsWho backs SiPhox Health
27+SiPhox Health valuation
SiPhox Health was valued at $185 million at its later-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has SiPhox Health raised?
SiPhox Health has raised $67.2 million in total; 2 of its rounds are on record. The largest on record was a $17 million Series A in Jul 2023.
SiPhox Health investors
27 investors are on record for SiPhox Health, including Y Combinator, Alumni Ventures, Khosla Ventures and Metaplanet Holdings. By type, the record holds 11 venture capital firms and 2 private investors. The Series A in Jul 2023 drew 15 investors.
Comparable companies
Comparable diagnostic equipment names by valuation on PrivateMarketView: Tasso ($229 million), NanoMosaic ($85 million) and AOA (Diagnostic Equipment) ($65 million).
About SiPhox Health
Operator of a biosensing platform intended to provide a handheld device that accepts disposable cartridges. The company's platform merges biochemistry and photonic chip technology and combines integrated photonics, electronics, and microfluidics to provide a sensitive readout of immunoassays and ribonucleic acid or deoxyribonucleic acid, enabling users to undertake tests at point-of-need and at-home diagnostics.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Burlington, MA, United States
- Founded
- 2020
- Employees
- 49
- Website
- siphoxhealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.